Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Huons Co's share price for the quarter that ended in Jun. 2026 was ₩26400. Huons Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 12 Mil. Therefore, Huons Co's market cap for the quarter that ended in Jun. 2026 was ₩307,613 Mil.
Huons Co's quarterly market cap
declined
from Dec. 2025 (₩319,265 Mil) to Mar. 2026 (₩295,378 Mil) but then
increased
from Mar. 2026 (₩295,378 Mil) to Jun. 2026 (₩307,613 Mil).
Huons Co's annual market cap
declined
from Dec. 2023 (₩455,962 Mil) to Dec. 2024 (₩323,539 Mil) and
declined
from Dec. 2024 (₩323,539 Mil) to Dec. 2025 (₩319,265 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Huons Co's Enterprise Value for Today is ₩382,056 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Huons Co Market Cap Related Terms
Huons Co Market Cap Historical Data
* Premium members only.
The historical data trend for Huons Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Huons Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huons Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Huons Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Huons Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Huons Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huons Co (XKRX:243070) has a Market Cap of ₩244,104 Mil as of Sep. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Huons Co and its competitors. According to the industry distribution chart, Huons Co ranks #544 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 53.2%.
Is Huons Co's Market Cap too high?
Huons Co's current Market Cap is ₩244,104 Mil. Based on the distribution chart, Huons Co ranks #544 out of 1023 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Huons Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Huons Co's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Huons Co ranks #544 out of 1023 companies for Market Cap. This places Huons Co in the lower half of its industry. The industry median Market Cap is 239.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 239.83, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Huons Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 239.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huons Co's current Market Cap is ₩244,104 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huons Co stock overvalued right now?
Based on GuruFocus' analysis, Huons Co (XKRX:243070) is currently considered Significantly Undervalued. The stock's GF Value™ is ₩31,318.12, compared to a current price of ₩20,950.00 — trading 33.1% below its estimated fair value. The current Market Cap is ₩244,104 Mil. Huons Co's overall GF Score™ is 89/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Huons Co (XKRX:243070), the current Market Cap is ₩244,104 Mil as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huons Co (XKRX:243070) Overvalued in 2026?
Based on GuruFocus' analysis, Huons Co stock appears to be undervalued.
The current stock price of ₩20,950.00 is trading 33.1% below its estimated GF Value™ of ₩31,318.12.
GuruFocus considers Huons Co to be Significantly Undervalued.
Key valuation signals for XKRX:243070:
Market Cap: ₩244,104 Mil
GF Value™: ₩31,318.12 vs. price of ₩20,950.00 (33.1% below fair value)
No single metric tells the full story. See the XKRX:243070 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huons Co Ltd is a Korean company. It is engaged in the manufacture and distribution of pharmaceutical products. The company produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermine, diet pills, and capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. It also produces ampoules, vials, cartridges, and caps for use of medicals, foods, and cosmetics.
89GF Score
Get the complete analysis for XKRX:243070
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:243070 has been successfully added to your 
